This company listing is no longer active
Allena Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Key information
131.1%
Debt to equity ratio
US$4.90m
Debt
Interest coverage ratio | n/a |
Cash | US$6.59m |
Equity | US$3.74m |
Total liabilities | US$14.07m |
Total assets | US$17.81m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0PJ's short term assets ($16.5M) exceed its short term liabilities ($10.4M).
Long Term Liabilities: 0PJ's short term assets ($16.5M) exceed its long term liabilities ($3.6M).
Debt to Equity History and Analysis
Debt Level: 0PJ has more cash than its total debt.
Reducing Debt: 0PJ's debt to equity ratio has increased from 36.6% to 131.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0PJ has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 0PJ has less than a year of cash runway if free cash flow continues to reduce at historical rates of 13.8% each year